Digital health tools tested to boost activity in metabolic syndrome patients

NCT ID NCT07236450

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study explored whether using a mobile app and a Fitbit Inspire 3 tracker can help adults with metabolic syndrome become more physically active. One hundred participants were split into two groups: one used the digital tools plus usual care, the other received usual care alone. Researchers measured changes in physical activity, health markers like cholesterol and blood sugar, and how often people used the app. The goal was to see if such digital tools can be practically used in primary care to support healthier lifestyles.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Mobile health application (Polis Saúde®) and wearable activity tracker (Fitbit Inspire 3)
What this could lead to
If it works, this could show that simple digital tools can help people with metabolic syndrome become more active and better manage their condition in everyday primary care.
What could go wrong
This is a small, completed study with 100 participants, so results may not apply to everyone. The app and tracker only encourage activity—they don't directly treat metabolic syndrome, and long-term benefits are uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METABOLIC SYNDROME (METS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

abdominal obesity-metabolic syndrome Health Behavior metabolic syndrome X Motor Activity Patient Participation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • USF Cruz de Celas

    Coimbra, Portugal, 3000-011, Portugal

More trials for these conditions

Other studies related to the condition(s) this trial covers.